propranolol - CISMeF

Preferred Label : propranolol;

MeSH definition : A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.;

MeSH synonym : propanolol;

MeSH hyponym : dociton; obsidan; anaprilin; propranolol hydrochloride; avlocardyl; betadren; inderal; AY-20694; AY 20694; AY20694; Obzidan; Hydrochloride, Propranolol; Anapriline;

Related MeSH term : rexigen; dexpropranolol;

MeSH CAS label : 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-;

MeSH Related Number : propranolol hydrochloride; 318-98-9 (Propranolol hydrochloride); 525-66-6 (Propranolol); dexpropranolol; F8A3652H1V; PG6KY07UD7;

Registry Number MeSH : 525-66-6;

Related CAS MeSH : PG6KY07UD7 (Dexpropranolol); F8A3652H1V (Propranolol hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Propranolol;

Codes EINECS : 208-378-0;

Is substance : O;

UNII : 9Y8NXQ24VQ;

InChIKey : AQHHHDLHHXJYJD-UHFFFAOYSA-N;

Details

Origin ID

D011433;

UMLS CUI

C0033497;

ATC code(s)
- propranolol and other combinations [ATC Code]
- propranolol and thiazides [ATC Code]
ATC code(s)
- propranolol [ATC Code]
- propranolol and other combinations [ATC Code]
- propranolol and thiazides [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Dexpropranolol [NCIt concept]
- Propranolol Hydrochloride [NCIt concept]
- Propranolol hydrochloride [Substance BNPC]
- Propranolol hydrochloride (substance) [SNOMED CT concept]
- dexpropranolol [Substance BNPC]
- propranolol [EMDN type]
- propranolol [medical devices type]
- propranolol hydrochloride [SNOMED Notion]
CISMeF manual mappings
- Poisoning caused by propranolol (disorder) [SNOMED CT concept]
- Propranolol measurement (procedure) [SNOMED CT concept]
- propranolol [Substance BNPC]
Currated CISMeF NLP mapping
- Propranolol [ICD-11 Extension code]
- Propranolol [LOINC component]
- Propranolol [ICHI extension code]
- Propranolol [SMS substance]
- Propranolol [NCIt concept]
- Propranolol (substance) [SNOMED CT concept]
- propranolol [SNOMED Notion]
Pharmacological action(s)
- adrenergic beta-antagonists [MeSH Descriptor]
- anti-arrhythmia agents [MeSH Descriptor]
- antihypertensive agents [MeSH Descriptor]
- vasodilator agents [MeSH Descriptor]
Record concept(s)
- AY-20694 [MeSH concept]
- anaprilin [MeSH concept]
- avlocardyl [MeSH concept]
- betadren [MeSH concept]
- dexpropranolol [MeSH concept]
- dociton [MeSH concept]
- inderal [MeSH concept]
- obsidan [MeSH concept]
- propranolol [MeSH concept]
- propranolol hydrochloride [MeSH concept]
- rexigen [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1,1-diethoxy-3-(1-naphthoxy)-2-propanol [MeSH Supplementary Concept]
- 1,3-bis(4-phenyl)-1H-1,2,3-triazolyl-2-propanolol [MeSH Supplementary Concept]
- 1-((2-(5-dimethylamino)naphthalene-1-sulfonylaminoethyl)amino)-3-(1-naphthaleneoxy)-2-propanol [MeSH Supplementary Concept]
- 1-(1,1-dimethylethylamino)-3-(1-naphthoxy)-2-propanol hydrochloride [MeSH Supplementary Concept]
- 1-(1-(2-benzodioxanylmethyl)-4-piperidiyl)amino-3-(1-naphthoxy)-2-propanol [MeSH Supplementary Concept]
- 1-(1-hydroxy-2-propylamino)-3-(1-naphthoxy)-2-propanol [MeSH Supplementary Concept]
- 3,4-dihydroxypropranolol [MeSH Supplementary Concept]
- 4'-hydroxypropranolol sulfate ester [MeSH Supplementary Concept]
- 4'-methylthiopropranolol [MeSH Supplementary Concept]
- 4,6-dihydroxypropranolol [MeSH Supplementary Concept]
- 4,8-dihydroxypropranolol [MeSH Supplementary Concept]
- 4-hydroxypropranolol [MeSH Supplementary Concept]
- 4-hydroxypropranolol glucuronide [MeSH Supplementary Concept]
- 4-hydroxypropranolol glycol [MeSH Supplementary Concept]
- 4-methylpropranolol [MeSH Supplementary Concept]
- 5-hydroxypropranolol [MeSH Supplementary Concept]
- 9-aminoacridylpropranolol [MeSH Supplementary Concept]
- BDGJ [MeSH Supplementary Concept]
- N-(2-hydroxy-3-naphthyloxypropyl)-N'-dansylethylenediamine [MeSH Supplementary Concept]
- N-(S-methyl)mercaptoethylpropranolol [MeSH Supplementary Concept]
- N-cyclopentyldeisopropylpropranolol [MeSH Supplementary Concept]
- N-desisopropylpropranolol [MeSH Supplementary Concept]
- N-hydroxypropranolol [MeSH Supplementary Concept]
- N-mercaptoethylpropranolol [MeSH Supplementary Concept]
- N-nitrosopropranolol [MeSH Supplementary Concept]
- O-acetylpropranolol [MeSH Supplementary Concept]
- O-isovaleryl propranolol [MeSH Supplementary Concept]
- ORF 12592 [MeSH Supplementary Concept]
- alpha-methylpropranolol [MeSH Supplementary Concept]
- butyryl propranolol [MeSH Supplementary Concept]
- dansylpropranolol [MeSH Supplementary Concept]
- docidrazin [MeSH Supplementary Concept]
- fluoropropranolol [MeSH Supplementary Concept]
- inderex [MeSH Supplementary Concept]
- inderide [MeSH Supplementary Concept]
- obsilazin [MeSH Supplementary Concept]
- palmitoyl propranolol [MeSH Supplementary Concept]
- pranolium [MeSH Supplementary Concept]
- propranolol FD [MeSH Supplementary Concept]
- propranolol N-aldonitrone [MeSH Supplementary Concept]
- propranolol glucuronide [MeSH Supplementary Concept]
- propranolol glycol [MeSH Supplementary Concept]
- propranolol laurate [MeSH Supplementary Concept]
- propranolol mustard [MeSH Supplementary Concept]
- propranolol stearate [MeSH Supplementary Concept]
- spiroprop [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing propranolol (medicinal product) [SNOMED CT concept]
- Product containing propranolol in oral dose form (medicinal product form) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing propranolol (medicinal product) [SNOMED CT concept]
- Propranolol [LOINC component]
- Propranolol [ICD-11 Extension code]
- Propranolol [NCIt concept]
- Propranolol (substance) [SNOMED CT concept]
- propranolol [ATC Code]
- propranolol [Substance BNPC]
- propranolol [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients